Molecular evaluation of metastatic prostatic cancer and the study on enhancement of their effects treating for non-tratment and refractory prostatic cancer.
Molecular evaluation of metastatic prostatic cancer and the study on enhancement of their effects treating for non-tratment and refractory prostatic cancer.
批准号:
09671618
负责人:
KOH Eitetsu
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998
中文摘要
1)前列腺癌血行微转移的分子生物学评价我们根据临床分期统计选择患者,这些患者预先保存了外周血PSA值、PSA mRNA等数据。本研究采用RT-PCR方法检测前列腺癌细胞系中雄激素受体(AR)和雌激素受体(ER)的表达,并对AR阴性前列腺癌细胞系中AR和ER的表达进行检测(PC 3、DU-145、TSUPr-1)和AR阳性细胞系(LNCap)暴露剂,如干扰素(INF)、5-氮杂胞苷、全反式视黄酸(ATRA),其具有潜在的细胞分化活性。(1)INF和ATRA对前列腺癌细胞株均无增殖抑制作用,而5-氮胞苷对这四种前列腺癌细胞株均有一定的增殖抑制作用。这一结果表明,这种诱导活性依赖于细胞周期或转录机制的启动子。(2)A从细胞周期的角度来看,这一系统与p16这一已知的抑癌基因有关。p16 mRNA在DU 145中表达较高,在LNCap中表达较低。此外,本身不表达p16蛋白的TSUPr-1和PC-3用5-氮胞苷诱导p16蛋白的表达,这意味着这四种前列腺细胞系的启动子区是去甲基化的。这一结果表明,细胞增殖抑制导致5-氮杂胞苷暴露于前列腺癌细胞系的高甲基化的可能性。下一步,我们计划评估与控制细胞周期相关的基因的表达,以证明端粒酶活性作为增殖和细胞分化的标志之一。
英文摘要
1)Molecular evaluation of hematogenous micro-metastasis from prostatic cancerStatistically we have selected patients according to their clinical stage, these patient had been preserved data such as PSA values, PSA mRNA from peripheral blood cells in advance. We are supposed to evaluate the relations between PSA value and the PSA expression using RT PCR.Now we are observing the clinical course these patients.2)Induction of expression in androgen receptor (AR) and estrogen receptor (ER) for four prostatic cancer cell lines.In our study, we evaluated an induction of AR and ER in AR-negative prostatic cell line (PC3, DU-145, TSUPr-1) and AR-positive cell line (LNCap) exposing agents such as interferon (INF), 5-azacytidine, all-trans retinoic acid (ATRA) which have an activity of potential cell differentiation.(1)There are no effects suppressing cell proliferation any cell lines using INF and ATRA.On the other hand, there are some effect suppressing cell proliferation using 5-azacytidine in these four prostatic cancer cell lines every concentrations. This results suggested that this induction activity is depend on cell cycle or promoter of transcription mechanism.(2)A cell cycle point of view, this system is related to p16 which is known to cancer suppressor gene. The p16 mRNA express high in DU145, low in LNCap. Furthermore TSUPr-1 and PC-3 which never express p16 protein in themselves induce the expression of p16 using 5-azacytidine.This means that the promoter region of these four prostatic cell line is demethylated. This result shows sate possibility that suppression of cell proliferation result in hypcmethylation exposing 5-azacytidine to prostatic cancer cell lines Next step we plan to evaluate the expression of genes which are related to controlling cell cycle, to demonstrate the telomerase activity as one of markers as proliferation and cell differentiation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Kitagawa, Y., Kunimi, K., Sato, H., Uchibayashi, T.and Namiki, M.: "Expression of messenger RNAs for membrane-types 1,2, and 3 matrix metalloproteinases in human renal cell carcinomas." J.Urol. (submitted on September 20th). (1998)
Kitakawa, Y.、Kunimi, K.、Sato, H.、Uchibayashi, T. 和 Namiki, M.:“人肾细胞癌中膜型 1,2 和 3 基质金属蛋白酶的信使 RNA 的表达。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kitagawa, Y., Kunimi, K., Ito, H., Sato, H., Uchibayashi, T., Okada, Y,Seiki, M.and Namiki, M.: "Expression and tissue localization of membrane-types 1,2, and 3 matrix metalloproteinases in human urothelial carcinomas." J.Urol.160. 1540-1545 (1998)
Kitakawa, Y.、Kunimi, K.、Ito, H.、Sato, H.、Uchibayashi, T.、Okada, Y、Seiki, M. 和 Namiki, M.:“膜类型 1 的表达和组织定位,
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
高 栄哲・並木幹夫: "DHEAの薬理作用と国内での使用状況" 医事新報. 3800. 108 (1997)
Eiji Ko 和 Mikio Namiki:“DHEA 的药理作用和日本的使用状况”Iji Shinpo。3800. 108 (1997)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kobayashi T.Uchibayashi T.: "A chick embryo model for mefastatic human prostate cancer" Eur.Urol.34. 154-160 (1998)
Kobayashi T.Uchibayashi T.:“转移性人类前列腺癌的鸡胚模型”Eur.Urol.34。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Iguchi K., Hamakake M., Shida M., Usami Y., Adachi T., Hajime Y., Koshida K., Uchibayashi K., Hirano K.: "Induction of necrosis by zinc in prostate carcinoma cells and identification of proteins increased in association with this induction." Eur.J.Biochem
Iguchi K.、Hamakake M.、Shida M.、Usami Y.、Adachi T.、Hajime Y.、Koshida K.、Uchibayashi K.、Hirano K.:“前列腺癌细胞中锌诱导坏死和蛋白质鉴定
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 12 条
A study of male infertility as genome diseases-Recombination of genome DNA and sperm typing-
-
批准号:21390438
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.32万
-
财政年份:2009
-
负责人:KOH Eitetsu
-
依托单位:
A study of male infertility regarding as genome disease focusing on function of human retrovirus elements
-
批准号:19390412
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.9万
-
财政年份:2007
-
负责人:KOH Eitetsu
-
依托单位:
Establishment of recovery spermatogenesis after chemotherapy due to the microenvironment modulation in seminiferous tubule
-
批准号:17591670
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.37万
-
财政年份:2005
-
负责人:KOH Eitetsu
-
依托单位:
Analysis and detecction of polymorphism of palindrome complex on Y chmmosome in idiopathic male infertility
-
批准号:15591677
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2003
-
负责人:KOH Eitetsu
-
依托单位:
Steroids metabolism and Cross-talk of steroid receptors in Prostatic cancer cells
-
批准号:11671542
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.43万
-
财政年份:1999
-
负责人:KOH Eitetsu
-
依托单位:
国内基金
海外基金
登录
查看更多内容
幽门螺杆菌诱导中性粒细胞CXCL8-C3AR1轴促进胃癌免疫逃逸的机制研究
-
批准号:2026JJ82697
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:邹品衡
-
依托单位:
小青龙汤经Nrf2/Keap1-ARE抗氧化通路修复AR鼻黏膜屏障的机制研究
-
批准号:2026JJ80719
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘昊斓
-
依托单位:
新型AR双重靶向降解剂克服前列腺癌患者CULLIN3突变相关二代抗雄药物耐药机制研究
-
批准号:JCZRLH202601217
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于增强现实(AR)技术的智能家居三维视听平台设计开发
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:沈维
-
依托单位:
基于增强现实(AR)技术的老年人便携式折叠座椅设计
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:路照林
-
依托单位:
多源传感融合穿戴式AR智能感知系统的设计与开发
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陶进
-
依托单位:
四神丸调节肠道菌群-A2AR/AMPK/NF-κB影响AQP4参与水液代谢治疗肾阳亏虚证泄泻的机制研究
-
批准号:2026JJ82596
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:彭昕欣
-
依托单位:
基于AR/Drd2通路的神经递质调控在儿童抽动障碍性别差异中的机制研究
-
批准号:JCZRLH202601507
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于“痰浊致呆”理论探讨涤痰汤调控CD39-A3AR-CREB信号轴改善血管性痴呆的分子机制
-
批准号:JCZRLH202601301
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
AI驱动VR/AR 场景化护理数字疗法治疗社区及神经康复病房阿尔茨海默病患者的临床研究
-
批准号:2026JJ81578
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:周紫菊
-
依托单位: